| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,209 |
27,877 |
$2.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,979 |
5,663 |
$548K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,038 |
8,836 |
$402K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,762 |
3,717 |
$356K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,247 |
3,200 |
$287K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,765 |
2,717 |
$256K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,032 |
3,801 |
$221K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,814 |
1,781 |
$180K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,013 |
5,512 |
$159K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,796 |
8,955 |
$134K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,406 |
4,062 |
$95K |
| G9153 |
Mapcp demonstration - physician incentive pool |
1,621 |
1,612 |
$76K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,506 |
1,438 |
$75K |
| 90461 |
|
2,967 |
2,889 |
$74K |
| 99070 |
|
12,894 |
11,500 |
$72K |
| 97802 |
|
3,881 |
3,762 |
$56K |
| 87428 |
|
925 |
898 |
$50K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,555 |
2,349 |
$49K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,552 |
3,520 |
$47K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,884 |
6,684 |
$46K |
| 99381 |
|
296 |
280 |
$27K |
| 87807 |
|
2,047 |
1,890 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,114 |
1,913 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
859 |
725 |
$21K |
| 83655 |
|
1,488 |
1,452 |
$18K |
| 69210 |
|
553 |
418 |
$17K |
| 36415 |
Collection of venous blood by venipuncture |
4,985 |
4,752 |
$12K |
| 81003 |
|
6,204 |
5,857 |
$12K |
| 96127 |
|
1,669 |
1,640 |
$10K |
| 85018 |
|
4,217 |
4,099 |
$9K |
| 88738 |
|
1,002 |
980 |
$4K |
| 86328 |
|
28 |
26 |
$1K |
| 86308 |
|
136 |
130 |
$851.12 |
| 94664 |
|
88 |
85 |
$808.32 |
| 94760 |
|
1,809 |
1,510 |
$807.96 |
| 97803 |
|
51 |
44 |
$666.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
275 |
211 |
$502.64 |
| 90621 |
|
67 |
66 |
$439.30 |
| 90734 |
|
281 |
275 |
$277.66 |
| 90651 |
|
813 |
796 |
$246.58 |
| 90619 |
|
152 |
151 |
$180.61 |
| 90686 |
|
1,644 |
1,620 |
$131.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
88 |
87 |
$94.72 |
| 90633 |
|
1,257 |
1,240 |
$68.39 |
| 90715 |
|
227 |
224 |
$40.16 |
| 90672 |
|
34 |
33 |
$30.68 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14 |
12 |
$30.33 |
| 90677 |
|
395 |
391 |
$0.00 |
| 90744 |
|
548 |
540 |
$0.00 |
| 90680 |
|
1,591 |
1,567 |
$0.00 |
| 90697 |
|
657 |
652 |
$0.00 |
| 90620 |
|
116 |
114 |
$0.00 |
| 90698 |
|
1,307 |
1,296 |
$0.00 |
| 90696 |
|
221 |
216 |
$0.00 |
| 90656 |
|
42 |
42 |
$0.00 |
| 90716 |
|
109 |
108 |
$0.00 |
| 90660 |
|
12 |
12 |
$0.00 |
| 90670 |
|
2,140 |
2,104 |
$0.00 |
| 90710 |
|
290 |
284 |
$0.00 |
| 90707 |
|
109 |
108 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
270 |
269 |
$0.00 |
| G0451 |
Development testing, with interpretation and report, per standardized instrument form |
50 |
50 |
$0.00 |
| 90685 |
|
96 |
95 |
$0.00 |